ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,508Medicare Part D Prescriptions Filled, Including Refills

Rank: 195 out of 944

$559K Total Retail Price of All Prescriptions

Rank: 155 out of 944

616 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 616 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 616 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 7,542 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
SIMVASTATIN 396 348 1 1
HYDROCHLOROTHIAZIDE 392 354 2 9
HYDROCODONE-ACETAMINOPHEN 346 253 S3 3 10
LEVOTHYROXINE SODIUM 333 254 4 2
OMEPRAZOLE 332 248 5 4
FUROSEMIDE 286 250 6 6
ATENOLOL 260 253 7 11
LISINOPRIL 247 188 8 3
AMLODIPINE BESYLATE 237 192 9 5
WARFARIN SODIUM 223 201 10 7
GABAPENTIN 203 165 11 18
ENALAPRIL MALEATE 199 183 12 43
METOPROLOL TARTRATE 159 137 13 8
METFORMIN HCL 149 125 14 12
ALENDRONATE SODIUM 130 101 15 20
FLUOXETINE HCL 110 101 16 48
RANITIDINE HCL 107 93 17 42
ATORVASTATIN CALCIUM 99 79 18 13
TAMSULOSIN HCL 98 86 19 27
TRAMADOL HCL 98 58 19 21
OXYCODONE HCL 91 18 S2 21 50
GLIPIZIDE 88 81 22 51
ALLOPURINOL 87 64 23 22
LOSARTAN POTASSIUM 86 79 24 16
MIRTAZAPINE 84 74 25 35
POTASSIUM CHLORIDE 76 55 26 15
MORPHINE SULFATE ER 71 19 S2 27 80
PREDNISONE 71 65 27 32
RISPERIDONE 70 53 29 78
DONEPEZIL HCL 68 68 30 24
LOVASTATIN 67 59 31 26
TRAZODONE HCL 65 29 32 45
NORTRIPTYLINE HCL 63 49 33 204
AMITRIPTYLINE HCL 61 51 R 34 79
DOXAZOSIN MESYLATE 59 46 35 60
TRIAMTERENE-HCTZ 55 52 36 33
NEXIUM 53 0 37 53
CRESTOR 52 48 38 28
DIOVAN 51 49 39 38
METFORMIN HCL ER 51 27 39 49
CYMBALTA 51 20 39 75
CYCLOBENZAPRINE HCL 50 20 R 42 86
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 6, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.